Research Advances in Benign Hematology


Each year, numerous BIDMC research faculty are:

  • Published in prestigious scientific and medical journals
  • Awarded prominent and highly competitive research grants
  • Recognized for far-ranging scientific achievement
  • Engaged in clinical trials, to bring research from the laboratory bench to the patient bedside

Clinical Trials

You may benefit from standard treatment protocols that improve the outcome of your particular blood disorder. Or you may qualify for one of our clinical trials - research studies that are designed to find better treatments for patients based on the most updated information from around the country.

As a founding member of the Dana Farber/Harvard Cancer Center (DF/HCC), Beth Israel Deaconess has access to a broad array of the most current clinical trials, including those that pertain to benign blood disorders. Ask your hematologist if you qualify for one of the blood-disorder trials we offer through the DF/HCC.

  • APIXABAN FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER: A PROSPECTIVE RANDOMIZED OPEN BLINDED END-POINT (PROBE) STUDY - THE CARA-VAGGIO STUDY  - Learn More.

  • A Double-Blind, Double-Dummy Phase 2 Randomized Study to Evaluate the Efficacy and Safety of Ruxolitinib Versus Anagrelide in Subjects with Essential Thrombocythemia Who Are Resistant to or In-tolerant of Hydroxyurea - Learn More.

  • Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) - Learn More.

  • A randomized, phase II study of weight-based versus standard dose enoxaparin thromboprophylaxis in high-risk hospitalized cancer patients.  - Learn More.

Updated November 2018.

Key Research Areas

BIDMC's research strengths pertaining to benign hematology are chiefly:

  • Coagulation and platelet disorders
  • Vascular biology, which interfaces with research pertaining to solid tumors
  • Cellular and molecular biology of hematopoiesis (how blood cells develop)
  • New treatment and prevention strategies for chronic anemia
  • The role of red blood cells in infectious disease and in the immune system
  • The role eosinophils, white blood cells, may play in allergies and infections